General EMBL spinoff Velabs and alytas enter into a licence agreement for senescence 07/01/2020 Annabelle Grimm
General Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity 03/09/2019 Annabelle Grimm
